Skip to main content

Table 1 Comparison of baseline characteristics stratified by the primary endpoint

From: Prognostic value of fibrinogen-to-albumin ratio combined with coronary calcification score in patients with suspected coronary artery disease

Variable

ALL

(4946)

Non-MACCEs

(4712)

MACCEs

(234)

P value

Age,years

62 (55–71)

62 (54–70)

65 (58–74)

0.001

Male, n (%)

3182 (64.3)

3021(64.1)

161(68.8)

0.144

Hypertension,n (%)

3415 (69.0)

3249 (69.0)

166 (70.9)

0.521

DM,n (%)

1532 (31.0)

1451 (30.8)

81 (34.6)

0.217

Family history of CAD, n (%)

693(14.0)

663(14.1)

30(12.8)

0.591

Smoking,n (%)

1223 (24.7)

1175 (24.9)

48 (20.5)

0.126

SBP,mmHg

129 (120–140)

129 (120–140)

129 (120–140)

0.713

DBP,mmHg

78 (70–84)

78 (70–84)

78 (70–83)

0.756

BMI, kg/m2

25.71 (23.49–28.4)

25.71 (23.44–28.41)

25.61 (23.71–28.09)

0.739

Creatinine,µmol/L

69.0 (58.97–80.00)

59 (58.6–79.68)

71 (62–84.76)

0.004

UA, mg/dL

320 (266–376.21)

320 (266–376)

325 (267–382.24)

0.268

eGFR, mL/min/1.73 m2

91.28 (69.45–117.50)

91.84 (70.02–118.08)

83.702 (62.8–109.23)

0.001

FBG, mmol/L

5.37 (4.75–6.82)

5.35 (4.75–6.78)

5.54 (4.82–7.64)

0.024

TG, mmol/L

1.62 (1.13–2.43)

1.62 (1.13–2.44)

1.47 (1.07–2.23)

0.037

TC, mmol/L

4.18 (3.52–4.88)

4.18 (3.52–4.87)

4.20(3.35–4.98)

0.657

HDL-C, mmol/L

1.11 (0.93–1.32)

1.11 (0.93–1.33)

1.05 (0.87–1.26)

0.002

LDL-C, mmol/L

2.72 (2.12–3.33)

2.72(2.13–3.32)

2.74 (2.07–3.50)

0.466

Total protein, g/L

67.7 (64.3–72.00)

67.7 (64.3–72.00)

67.45 (63.8–71.9)

0.71

Albumin,g/L

41.2(38.64–43.70)

41.2(38.7–43.73)

40.55(37.50–43.10)

0.001

Fibrinogen, g/L

3.27(2.82–3.69)

3.26 (2.81–3.68)

3.37 (3.03–3.83)

0.001

FAR

0.0787(0.0671–0.0913)

0.0785 (0.0669–0.0909)

0.0833 (0.0727–0.0974)

0.001

CACS

75.55(18.20–259.73)

73.20 (17.5–253.3)

156.40 (39.2–498.1)

0.001

Medication

 Aspirin, n (%)

2365(47.8)

2260(48.0)

105(44.9)

0.356

 β-blocker, n (%)

1528(30.9)

1465(31.1)

63 (26.9)

0.178

 ACEI/ARB, n (%)

1357(27.4)

1317(27.9)

40(17.1)

0.001

 Statins, n (%)

2639(53.4)

2525(53.6)

114 (48.7)

0.145

 CCB, n (%)

1305 (26.4)

1268 (26.9)

37(15.8)

0.001

  1. Values are median (25th to 75th percentile) or number (%)
  2. MACCEs major adverse cardiovascular and cerebral events, FAR fibrinogen-to-albumin ratio, BMI body mass index, DM diabetes mellitus, CAD coronary artery disease, FBG fasting blood glucose, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, eGFR estimated glomerular filtration rate, CACS Coronary calcification score, ACEI angiotensin converting enzyme inhibitors, ARB angiotensin receptor blockers, CCB calcium-channel blocker
  3. p-values < 0.05 were considered significant